HPV Archives - Infectious Disease Advisor

General Infectious Disease

HPV Vaccination Rates Low for Young Adults

May 10, 2021

Rates low for 18- to 21-year-olds reporting vaccination at any age or initiating in young adulthood

Prevention

HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years

May 7, 2021

For most of the study period, higher rates of HPV vaccination initiation and up-to-date rates were seen for non hispanic blacks.

Diagnostics

HPV Biomarkers, Survival Linked to High-Grade Esophageal Dysplasia, Adenocarcinoma

By

Bradley van Paridon

March 27, 2020

Low expression of the HPV-related marker cyclin D1 appears to be an independent prognostic marker in Barrett high-grade dysplasia and esophageal adenocarcinoma.

Double gloves Boot covers that are waterproof and go to at least mid-calf or leg covers Single-use fluid resistant or impermeable gown that extends to at least mid-calf or coverall without integrated hood Respirators, including either N95 respirators or powered air purifying respirator (PAPR) Single-use, full-face shield that is disposable Surgical hoods to ensure complete coverage of the head and neck Apron that is waterproof and covers the torso to the level of the mid-calf (and that covers the top of the boots or boot covers) should be used if Ebola patients have vomiting or diarrhea

Practice Management

Many Pelvic Exams, Pap Tests Unnecessary in Teenagers and Young Adults

January 8, 2020

More than half of bimanual exams, >70 percent of Pap tests in women aged 15 to 20 years unnecessary

News, Prevention

Studies Confirm Safety of 9-Valent HPV Vaccination

November 25, 2019

Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites

Prevention

Mailing HPV Kits to Underscreened Women Can Increase Screening

November 12, 2019

No significant difference found in detection of CIN2+ or treatment with intervention versus usual care

Prevention

One Dose of HPV Vaccine May Be Sufficient in Certain Situations

August 5, 2019

One dose compared with two or three doses in preventing cervical precancer in high-coverage settings

The HPV vaccine protects against the human papillomaviruess and causes most cervical cancers. It is recommended for male and female patients aged 11 to 12 years. Stressing the importance of the vaccine to boys, especially, can help reduce spread of the disease. The vaccine can be administered to female patients aged 26 and under and male patients aged 21 years and younger.

Prevention

Efficacy and Herd Effects of HPV Vaccination Programs

By

Bradley van Paridon

July 25, 2019

An updated systematic review and meta-analysis of the efficacy of HPV vaccines revealed compelling evidence for the considerable effect of HPV vaccination programs on HPV infections and cervical intraepithelial neoplasia grade 2+ (CIN2+) among girls and women, and on anogenital warts diagnoses among girls, women, boys, and men. The review, published in The Lancet, included…